Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen; Reimar Wernich Thomsen; Anton Pottegård; Filip Krag Knop; Henrik Toft Sørensen

doi:10.2337/dc18-0999

Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen
, Reimar Wernich Thomsen
, Anton Pottegård
, Filip Krag Knop
, Henrik Toft Sørensen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

103 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Diabetes Care
Vol/bind	41
Udgave nummer	9
Sider (fra-til)	e133-e135
ISSN	0149-5992
DOI	https://doi.org/10.2337/dc18-0999
Status	Udgivet - 1. sep. 2018

Dokumenter og links

10.2337/dc18-0999

Open Access VersionAccepteret manuskript, 157 KB

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{36ac463524cb4c56bc7862b6d92d16ab,

title = "Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide",

author = "Knudsen, \{Jakob Sch{\"o}llhammer\} and Thomsen, \{Reimar Wernich\} and Anton Potteg{\aa}rd and Knop, \{Filip Krag\} and S{\o}rensen, \{Henrik Toft\}",

year = "2018",

month = sep,

day = "1",

doi = "10.2337/dc18-0999",

language = "English",

volume = "41",

pages = "e133--e135",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "9",

}

TY - JOUR

T1 - Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

AU - Knudsen, Jakob Schöllhammer

AU - Thomsen, Reimar Wernich

AU - Pottegård, Anton

AU - Knop, Filip Krag

AU - Sørensen, Henrik Toft

PY - 2018/9/1

Y1 - 2018/9/1

U2 - 10.2337/dc18-0999

DO - 10.2337/dc18-0999

M3 - Journal article

C2 - 30002200

SN - 0149-5992

VL - 41

SP - e133-e135

JO - Diabetes Care

JF - Diabetes Care

IS - 9

ER -